ZYDUSLIFE Zydus Lifesciences Limited
Healthcare
LTP
1,186
CHG · %
+0 (+0.00%)
VOL · TODAY
—
PREV CLOSE
1,186
Today's range0 · 0
1,186
52-week range0 · 1,232.1
1,186
Loading candles…
Zydus Lifesciences Ltd., formed in 1995 following the restructuring of the Zydus group and the establishment of Cadila Healthcare, is a global pharmaceutical company engaged in the discovery, development, manufacturing, and marketing of healthcare therapies. The company operates across three main segments: generic pharmaceuticals, branded pharmaceuticals, and consumer wellness. Its product offerings include Active Pharmaceutical Ingredients (APIs), finished formulations, and therapies in oncology, cardiology, and gastrointestinal health. Zydus Lifesciences maintains extensive research and development capabilities with a vertically integrated structure spanning from APIs to finished formulations. Operating within the pharmaceuticals and healthcare industries, the company serves a global market. Since its inception, the group's turnover expanded substantially from Rs. 250 crores in 1995 to over Rs. 14,253 crores in FY20.
ZYDUSLIFE is not part of any active scan today.
This page is a live market overview for Zydus Lifesciences Limited (ZYDUSLIFE) on the BSE. As a listed security, Zydus Lifesciences Limited is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for ZYDUSLIFE before placing trades on tick2trade.
As of the latest feed, ZYDUSLIFE last traded at ₹1,186 on BSE, up ₹0 (0.00%) from the previous close of ₹1,186. Today's session range is ₹0 – ₹0, against a 52-week band of ₹0 – ₹1,232.1. Traded volume today stands at — shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for ZYDUSLIFE in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether ZYDUSLIFE is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for Zydus Lifesciences Limited before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in ZYDUSLIFE. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated ZYDUSLIFE option chain page linked from this overview.
// similar in healthcare326 total